SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Dave Gore's Trades That Make Sense

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dave Gore who started this subject4/20/2002 5:28:24 PM
From: Dave Gore  Read Replies (2) of 16631
 
HQNT ---- PM me if you want to be added to the email list.

NOTE: THIS IS A REFERENCE POST FOR FUTURE POSTINGS.

DISCLAIMER (starter D.D. and info on compensation; please read carefully before investing and do thorough D.D. yourself).

*******

H-QUOTIENT, INC., is a publicly traded company (stock symbol: HQNT) that creates and produces state-of-the art computer software systems that collect and act upon real-time information critical to improving the delivery of healthcare. Company Website: hquotient.com

What exactly do HQNT's products offer clients?
hquotient.com

Significant New Management
Recently hired the former Senior VP of Freddie Mac as VP of Operations to market their medical products, including LabQuotient, which they announced publicly should add $5M Net to their bottom line. Noted medical scientist, Dr. Laipply, has also joined HQNT and purchased 1M shares of stock (see PR links below).

STARTER D.D.
** Two year high/low: $7.00+ to .16 (major seller of 3M shares done with, according to company representatives and DTC's)

** Very little debt (about $200K per CEO) unlike most penny stocks, of course

** Shares O/S = 25M (12M float; 4M “true float”, per CEO)

** Should announce audited financials of $1M+ in annual earings from operations prior to end of April (see PR below)

YAHOO INFO:
finance.yahoo.com

CHART:
bigcharts.marketwatch.com.

RECENT DEVELOPMENTS
** Announced unaudited net earnings from operations in excess of $1M; audited financials supposed to be out next week per CEO.

** Announced $5M projected Net for LabQuotient (see PR below)

** Added two very high quality team members recently (who presumably did their own DD on the company)

(1) Dr. Thomas Laipply, Dir. of Molecular Tissue Pathology, Nichols Institute at Quest Diagnostics (see recent PR's below) and his share purchases on the open market.

(2) Laurence Burden, V.P. of Operations to help market HQNT’s medical software products. Look at his resume (from recent PR below)

- "As corporate VP and Chief Information Officer (CIO) and member of the turnaround team, he helped make possible the $2.3 billion sale of Firestone to Bridgestone" Also, "As Senior VP and CIO of Freddie Mac, he redesigned its computer systems and financial engineering systems, providing the basis for hundreds of millions in revenues and savings."

FILING INFO AND RECENT NEWS:
Please verify yourself these and other figures below by looking at the current filings at: siliconinvestor.com and especially the new filing when it comes out.

H-Quotient, Inc., Announces Record Annual Earnings
VIENNA, Va., Apr 19, 2002 /PRNewswire-FirstCall via COMTEX/ -- H-Quotient, Inc., (OTC Bulletin Board: HQNT chart, msgs) announced earnings from operations in excess of 1,000,000 for the year ending December 31, 2001, compared with losses in every prior year. Additional earnings were recorded from investments through our subsidiary Quotient Capital Corporation.
siliconinvestor.com

H-Quotient, Inc., Announces LabQuotient; $5 Million Net Projected
VIENNA, Va., Mar 25, 2002 /PRNewswire-FirstCall via COMTEX/ -- H-Quotient, Inc., (OTC Bulletin Board: HQNT chart, msgs) and Dr. Thomas C. Laipply, MD, FCAP, FIAP, Director of Molecular Tissue Pathology, Nichols Institute at Quest Diagnostics announced LabQuotient, a relational database for improving and monitoring medical test ordering. The product is expected to be ready for market this summer. Pre-production orders have been received. Further details will be announced in a subsequent release.

H-Quotient, Inc., is projected to earn net income of $5 million in the product's first year. All income will be recurring and is expected to grow substantially because the universe for this revolutionary product includes clinical doctors, dentists, veterinarians, emergency rooms, urgent care centers, insurance companies, HMOs, hospital quality assurance personnel, commercial laboratories, and pharmaceutical-drug companies.

****
H-Quotient, Inc., Announces Appointment of Laurence T. Burden As V.P. of Operations ---- Check his resume:
siliconinvestor.com

****
H-Quotient, Inc., Announces Scientific Advisory Board Chairman
siliconinvestor.com

****

H-Quotient, Inc., Announces More Than 1 Million Shares Purchased by Dr. Laipply
siliconinvestor.com

****
H-Quotient, Inc. Announces LabQuotient Prototype; Full-Scale Sales Effort to Commence
siliconinvestor.com

****
H-Quotient, Inc., Announces Development of Blood Utilization Software
siliconinvestor.com

****
OTHER NEWS
siliconinvestor.com

Do your own DD. You may want to call Doug Kohn, the CEO, at 703-821-3434

DISCLAIMER: As always, do your own Due Diligence. The information posted by me is believed to be accurate, but cannot be guaranteed. Some forward-looking statements or opinions expressed by myself or others on this thread or others may not come true. Also, I have chosen to state from the first post I made after I was hired a couple weeks ago, that I am being compensated by the Company to help bring some honest exposure to it and try to attract longer term shareholders who believe in its potential after doing their own Due Diligence. I have entered into a verbal agreement to be paid 15k shares of 1 year RESTRICTED stock (meaning I cannot sell it until at least April 2003). Some may not want to buy HQNT because of that and that is certainly their right. However, it could be stated that those who do receive compensation, if they are smart, are usually much more careful about being honest than those who are not. Why? Because they are easy targets for prosecution by the SEC should they purposely lie or "pump and dump". I will also state that I have not been paid any shares yet by the Company, and again, as I said will not be able to sell them for a year after I do. I also currently hold 6,500 shares of stock that I purchased on the open market from 57 to 74 cents recently.

Good luck, whatever you decide to do. I will keep supplying information from time to time and if anyone PM's me, I will be happy to add them to a e-mail list. I hope many will keep an open mind and consider my integrity and Forbe Magazine award and check out this company as a potential longer term holding.

thanks,
Dave (Bob)

PS- Please be assured that unlike most on SI who never say anything about receieving compensation from companies, I will always be upfront about it and state it publicly immediately, should it happen in the future.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext